Cui Q - Search Results

1

eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis.

Ma S, Dong Z, Cui Q, Liu JY, Zhang JT. Ma S, et al. Among authors: cui q. Cancer Lett. 2021 Mar 1;500:11-20. doi: 10.1016/j.canlet.2020.12.009. Epub 2020 Dec 8. Cancer Lett. 2021. PMID: 33301799 Review.

2

A novel survivin dimerization inhibitor without a labile hydrazone linker induces spontaneous apoptosis and synergizes with docetaxel in prostate cancer cells.

Peery R, Cui Q, Kyei-Baffour K, Josephraj S, Huang C, Dong Z, Dai M, Zhang JT, Liu JY. Peery R, et al. Among authors: cui q. Bioorg Med Chem. 2022 Jul 1;65:116761. doi: 10.1016/j.bmc.2022.116761. Epub 2022 Apr 28. Bioorg Med Chem. 2022. PMID: 35504208 Free PMC article.

3

Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid Synthase.

Beebe J, Josephraj S, Wang CJ, Danielson J, Cui Q, Huang C, Barlow L, Zhang RH, Zhang T, Nakshatri H, Dong Z, Li X, Liu JY, Zhang JT. Beebe J, et al. Among authors: cui q. J Med Chem. 2022 Oct 27;65(20):13681-13691. doi: 10.1021/acs.jmedchem.2c00642. Epub 2022 Oct 18. J Med Chem. 2022. PMID: 36257066

4

Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.

Cui Q, Huang C, Liu JY, Zhang JT. Cui Q, et al. J Med Chem. 2023 Dec 28;66(24):16515-16545. doi: 10.1021/acs.jmedchem.3c01130. Epub 2023 Dec 13. J Med Chem. 2023. PMID: 38092421 Review.

5

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.

Fan YF, Zhang W, Zeng L, Lei ZN, Cai CY, Gupta P, Yang DH, Cui Q, Qin ZD, Chen ZS, Trombetta LD. Fan YF, et al. Among authors: cui q. Cancer Lett. 2018 May 1;421:186-198. doi: 10.1016/j.canlet.2018.01.021. Epub 2018 Jan 11. Cancer Lett. 2018. PMID: 29331420

6

Overexpression of ABCB1 confers resistance to FLT3 inhibitor FN-1501 in cancer cells: in vitro and in vivo characterization.

Zhang M, Huang MN, Dong XD, Cui QB, Yan Y, She ML, Feng WG, Zhao XS, Wang DT. Zhang M, et al. Am J Cancer Res. 2023 Dec 15;13(12):6026-6037. eCollection 2023. Am J Cancer Res. 2023. PMID: 38187048 Free PMC article.

7

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance.

Wang JQ, Yang Y, Cai CY, Teng QX, Cui Q, Lin J, Assaraf YG, Chen ZS. Wang JQ, et al. Among authors: cui q. Drug Resist Updat. 2021 Jan;54:100743. doi: 10.1016/j.drup.2021.100743. Epub 2021 Jan 13. Drug Resist Updat. 2021. PMID: 33513557 Review.

8

Navigating Calcium and Reactive Oxygen Species by Natural Flavones for the Treatment of Heart Failure.

Yu T, Huang D, Wu H, Chen H, Chen S, Cui Q. Yu T, et al. Among authors: cui q. Front Pharmacol. 2021 Nov 9;12:718496. doi: 10.3389/fphar.2021.718496. eCollection 2021. Front Pharmacol. 2021. PMID: 34858167 Free PMC article. Review.

9

Modulating ROS to overcome multidrug resistance in cancer.

Cui Q, Wang JQ, Assaraf YG, Ren L, Gupta P, Wei L, Ashby CR Jr, Yang DH, Chen ZS. Cui Q, et al. Drug Resist Updat. 2018 Nov;41:1-25. doi: 10.1016/j.drup.2018.11.001. Epub 2018 Nov 14. Drug Resist Updat. 2018. PMID: 30471641 Review.

10

Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.

Narayanan S, Cai CY, Assaraf YG, Guo HQ, Cui Q, Wei L, Huang JJ, Ashby CR Jr, Chen ZS. Narayanan S, et al. Among authors: cui q. Drug Resist Updat. 2020 Jan;48:100663. doi: 10.1016/j.drup.2019.100663. Epub 2019 Nov 11. Drug Resist Updat. 2020. PMID: 31785545 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,857 results

Search Page